Clinical Trial Results: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) [Phase 3]

View source ↗

Summary

Phase 3 study LOGOS evaluated PT010 in adults and adolescents with inadequately controlled asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT010

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02